BridgeBio Pharma Inc
NASDAQ:BBIO

Watchlist Manager
BridgeBio Pharma Inc Logo
BridgeBio Pharma Inc
NASDAQ:BBIO
Watchlist
Price: 75.15 USD 1.46% Market Closed
Market Cap: 14.5B USD

Intrinsic Value

The intrinsic value of one BBIO stock under the Base Case scenario is hidden USD. Compared to the current market price of 75.15 USD, BridgeBio Pharma Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

BBIO Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
BridgeBio Pharma Inc

Intrinsic Value History
Dive into the past to invest in the future

BBIO looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether BBIO usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about BBIO?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is BBIO valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for BridgeBio Pharma Inc.

Explain Valuation
Compare BBIO to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BBIO?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
BridgeBio Pharma Inc

Current Assets 839.4m
Cash & Short-Term Investments 645.9m
Receivables 116.5m
Other Current Assets 76.9m
Non-Current Assets 158.9m
Long-Term Investments 92.2m
PP&E 12.4m
Intangibles 28.8m
Other Non-Current Assets 25.5m
Current Liabilities 216.6m
Accounts Payable 18.7m
Accrued Liabilities 180.2m
Other Current Liabilities 17.7m
Non-Current Liabilities 2.7B
Long-Term Debt 2.7B
Other Non-Current Liabilities 27.6m
Efficiency

Free Cash Flow Analysis
BridgeBio Pharma Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
BridgeBio Pharma Inc

Revenue
353.8m USD
Cost of Revenue
-14.9m USD
Gross Profit
338.8m USD
Operating Expenses
-933.8m USD
Operating Income
-595m USD
Other Expenses
-202.2m USD
Net Income
-797.1m USD
Fundamental Scores

BBIO Profitability Score
Profitability Due Diligence

BridgeBio Pharma Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Exceptional ROE
ROIC is Increasing
Exceptional Gross Margin
hidden
Profitability
Score

BridgeBio Pharma Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

BBIO Solvency Score
Solvency Due Diligence

BridgeBio Pharma Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Positive Net Debt
Long-Term Solvency
hidden
Solvency
Score

BridgeBio Pharma Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BBIO Price Targets Summary
BridgeBio Pharma Inc

Wall Street analysts forecast BBIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BBIO is 85.26 USD with a low forecast of 42.63 USD and a high forecast of 115.5 USD.

Lowest
Price Target
42.63 USD
43% Downside
Average
Price Target
85.26 USD
13% Upside
Highest
Price Target
115.5 USD
54% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

BridgeBio Pharma Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for BBIO is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

BBIO Insider Trading
Buy and sell transactions by insiders

BBIO News

Other Videos
What is the Intrinsic Value of one BBIO stock?

The intrinsic value of one BBIO stock under the Base Case scenario is hidden USD.

Is BBIO stock undervalued or overvalued?

Compared to the current market price of 75.15 USD, BridgeBio Pharma Inc is hidden .

Back to Top